| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Zuraiz Chaudhary is See Remarks at TTRX. Zuraiz Chaudhary's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $119K at current prices.
Historically, Zuraiz Chaudhary's trades have earned a strong insider score of 80/100 across 5 rated trades. Over a 12-month horizon, the one trade was profitable, with an average 12-month return of +100.0%.
Net of sales, the TTRX filings show accumulation of 12,500 shares.
Zuraiz Chaudhary has 6 Form 4 filings on record from October 2025 to April 2026, all as Turn Therapeutics (TTRX), 2025–2026.
The 7 reported transactions were 5 open-market purchases and 2 option or other derivative awards.
Counted by filing, the open-market trades come to 4 purchases worth about $50K and no sales.
The largest open-market purchase was 5,050 shares of TTRX at an average $4.95 on October 23, 2025, about $25K. Twelve months later TTRX was up 108%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | TTRX Turn Therapeutics Inc. | See Remarks | Buy | 2,500 | $3.50 | $8,750.00 | +25.0% | +9.2% | - | |
| Nov 21, 2025 | TTRX Turn Therapeutics Inc. | See Remarks | Buy | 2,450 | $2.89 | $7,074.50 | +32.5% | +4.0% | - | |
| Nov 17, 2025 | TTRX Turn Therapeutics Inc. | See Remarks | Buy | 2,500 | $3.62 | $9,050.00 | +49.5% | -8.6% | - | |
| Oct 23, 2025 | TTRX Turn Therapeutics Inc. | See Remarks | Buy | 5,050 | $4.95 | $24,997.50 | New | -6.3% | +107.7% |